Cargando…

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals – a cross-sectional observational study

BACKGROUND: Cerebrospinal fluid (CSF) biomarkers Aβ1-42, t-tau and p-tau have a characteristic pattern in Alzheimer’s Disease (AD). Their roles in HIV-associated neurocognitive disorder (HAND) remains unclear. METHODS: Adults with chronic treated HIV disease were recruited (n = 43, aged 56.7 ± 7.9;...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cysique, Lucette A, Hewitt, Timothy, Croitoru-Lamoury, Juliana, Taddei, Kevin, Martins, Ralph N, Chew, Constance SN, Davies, Nicholas NWS, Price, Patricia, Brew, Bruce J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386081/ https://www.ncbi.nlm.nih.gov/pubmed/25880550 http://dx.doi.org/10.1186/s12883-015-0298-0

Ejemplares similares

APOE ε4 Allele Is Associated with Elevated Levels of CSF VILIP-1 in Preclinical Alzheimer’s Disease
por: Wang, Lijun, et al.
Publicado: (2020)

Peripheral Blood Mononuclear Cells HIV DNA Levels Impact Intermittently on Neurocognition
por: Cysique, Lucette A., et al.
Publicado: (2015)

Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition
por: Wesenhagen, Kirsten E.J., et al.
Publicado: (2022)

Covertly active and progressing neurochemical abnormalities in suppressed HIV infection
por: Cysique, Lucette A., et al.
Publicado: (2018)

Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
por: Oh, Esther S., et al.
Publicado: (2018)

The Relationship of CSF and Plasma Cytokine Levels in HIV Infected Patients with Neurocognitive Impairment
por: Yuan, Lin, et al.
Publicado: (2015)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

Association of CSF GAP-43 and APOE ε4 with Cognition in Mild Cognitive Impairment and Alzheimer’s Disease
por: Zhu, Yueli, et al.
Publicado: (2022)

HIV-Associated Neurocognitive Disorders: A Global Perspective
por: Saloner, Rowan, et al.
Publicado: (2017)

Correction: Abnormal CSF amyloid-β42 and tau levels in hip fracture patients without dementia
Publicado: (2018)

The APOE ε4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2
por: Gispert, Juan Domingo, et al.
Publicado: (2016)

Symptomatic amyloid‐related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab
por: VandeVrede, Lawren, et al.
Publicado: (2020)

Clinicopathologic characterization and abnormal autophagy of CSF1R-related leukoencephalopathy
por: Tian, Wo-Tu, et al.
Publicado: (2019)

Validity of Cognitive Screens for HIV-Associated Neurocognitive Disorder: A Systematic Review and an Informed Screen Selection Guide
por: Kamminga, Jody, et al.
Publicado: (2013)

Association of APOE Serum Levels and APOE ε2, ε3, and ε4 Alleles with Optic Neuritis
por: Momkute, Liucija, et al.
Publicado: (2022)

Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury
por: Suzuki, Kazuo, et al.
Publicado: (2022)

Pulvinar sign and abnormally high CSF WBC in posterior reversible encephalopathy syndrome
por: Kagabo, Whitney, et al.
Publicado: (2020)

Brain amyloid in virally suppressed HIV-associated neurocognitive disorder
por: Howdle, Gemma C., et al.
Publicado: (2020)

Meaningful cognitive decline is uncommon in virally suppressed HIV, but sustained impairment, subtle decline and abnormal cognitive aging are not
por: Aung, Htein Linn, et al.
Publicado: (2022)

Common BACE2 Polymorphisms are Associated with Altered Risk for Alzheimer’s Disease and CSF Amyloid Biomarkers in APOE ε4 Non-Carriers
por: Huentelman, Matt, et al.
Publicado: (2019)

Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

Construction of Recombinant Human GM-CSF and GM-CSF-ApoA-I Fusion Protein and Evaluation of Their Biological Activity
por: Pykhtina, Mariya, et al.
Publicado: (2021)

Homozygous mutation in CSF1R causes brain abnormalities, neurodegeneration, and dysosteosclerosis (BANDDOS)
por: Daghagh, Hossein, et al.
Publicado: (2023)

CSF and Blood Levels of GFAP in Alexander Disease
por: Jany, Paige L., et al.
Publicado: (2015)

Evaluating the levels of CSF and serum factors in ALS
por: Guo, Jie, et al.
Publicado: (2017)

Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer’s disease course
por: Liguori, Claudio, et al.
Publicado: (2020)

Value of CSF-Cl, CSF-GS, CSF-MALB, and CSF-ADA in Differential Diagnosis of Secondary Hydrocephalus
por: Huang, Junzhang, et al.
Publicado: (2022)

CSF Levels of Angiopoietin-2 Do Not Differ between Patients with CSF Fluid Leakage Syndrome and Controls
por: Pul, Refik, et al.
Publicado: (2015)

Regulation of CSF and Brain Tissue Sodium Levels by the Blood-CSF and Blood-Brain Barriers During Migraine
por: Ghaffari, Hamed, et al.
Publicado: (2020)

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4
por: Andreasson, U, et al.
Publicado: (2014)

Is There Any Evidence of Premature, Accentuated and Accelerated Aging Effects on Neurocognition in People Living with HIV? A Systematic Review
por: Aung, Htein Linn, et al.
Publicado: (2020)

Retracted: Value of CSF-Cl, CSF-GS, CSF-MALB, and CSF-ADA in Differential Diagnosis of Secondary Hydrocephalus
por: Imaging, Contrast Media & Molecular
Publicado: (2023)

An Efficient Combination among sMRI, CSF, Cognitive Score, and APOE ε4 Biomarkers for Classification of AD and MCI Using Extreme Learning Machine
por: Khatri, Uttam, et al.
Publicado: (2020)

Task switching reveals abnormal brain-heart electrophysiological signatures in cognitively healthy individuals with abnormal CSF amyloid/tau, a pilot study
por: Arechavala, Rebecca Johnson, et al.
Publicado: (2021)

Adenosine Deaminase Levels in CSF of Tuberculous Meningitis Patients
por: Gupta, Bharat Kumar, et al.
Publicado: (2010)

CSF p-Tau levels in the prediction of Alzheimer's disease
por: Kandimalla, Ramesh J. L., et al.
Publicado: (2013)

Elevated CSF histamine levels in multiple sclerosis patients
por: Kallweit, Ulf, et al.
Publicado: (2013)

Levels of ADAM10 are reduced in Alzheimer’s disease CSF
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2018)

Rh-CSF1 attenuates neuroinflammation via the CSF1R/PLCG2/PKCε pathway in a rat model of neonatal HIE
por: Hu, Xiao, et al.
Publicado: (2020)

Influence of APOE Genotype on Alzheimer's Disease CSF Biomarkers in a Spanish Population
por: Monge-Argilés, J. A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t80v1pmdhff71cmaup3q03q5j8